Precision Medicine Podcast: Inherited Cancer Risk — What Every Patient and Clinician Needs to Know

Most inherited cancer risk goes undetected — not because the tools don’t exist, but because patients and clinicians aren’t asking the right questions. In this episode of Trapelo Health’s Bringing Precision Medicine to Everyone series, Ellen Matloff joins Dr. Angella Charnot-Katsikas, Chief Medical Officer at Palmetto GBA, to explain how to identify inherited cancer risk before cancer takes hold. They cover the limitations of consumer tests like 23andMe, systemic barriers to access, and practical steps for integrating genetic risk assessment into routine care.
Listen here